549 results
Page 2 of 28
8-K
EX-4.1
n1120aq o3y
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
ybtvn36ivwrcixv5xa
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-5.1
1o6en2 wnz
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
l4hwnegcbaas44sa
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
424B5
qenl8qngsh kfu
30 Jan 24
Prospectus supplement for primary offering
6:05am
DEFA14A
5jhlxce
2 Jan 24
Additional proxy soliciting materials
8:10am
8-K
EX-5.2
0vi6s01pjf lobqjqe
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-4.2
jtbag5wqn3c3xt6tg0
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-4.1
g5al3i116hl4205r1
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-5.1
0qmnfy
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-1.1
up8g wvlebxm3m
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
i3xgenzkburg4finiwo
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
262d1x0
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B3
ewqukm kpu
29 Sep 23
Prospectus supplement
4:56pm